{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T15:21:58Z","timestamp":1781104918723,"version":"3.54.1"},"reference-count":35,"publisher":"National Academy of Sciences","issue":"42","content-domain":{"domain":["www.pnas.org"],"crossmark-restriction":true},"short-container-title":["Proc. Natl. Acad. Sci. U.S.A."],"published-print":{"date-parts":[[2010,10,19]]},"abstract":"<jats:p>\n                    Bioterrorism poses a daunting challenge to global security and public health in the 21st century.\n                    <jats:italic>Variola major<\/jats:italic>\n                    virus, the etiological agent of smallpox, and\n                    <jats:italic>Bacillus anthracis<\/jats:italic>\n                    , the bacterial pathogen responsible for anthrax, remain at the apex of potential pathogens that could be used in a bioterror attack to inflict mass casualties. Although licensed vaccines are available for both smallpox and anthrax, because of inadequacies associated with each of these vaccines, serious concerns remain as to the deployability of these vaccines, especially in the aftermath of a bioterror attack involving these pathogens. We have developed a single vaccine (Wyeth\/IL-15\/PA) using the licensed Wyeth smallpox vaccine strain that is efficacious against both smallpox and anthrax due to the integration of immune-enhancing cytokine IL-15 and the protective antigen (PA) of\n                    <jats:italic>B. anthracis<\/jats:italic>\n                    into the Wyeth vaccinia virus. Integration of IL-15 renders Wyeth vaccinia avirulent in immunodeficient mice and enhances anti-vaccinia immune responses. Wyeth\/IL-15\/PA conferred sterile protection against a lethal challenge of\n                    <jats:italic>B. anthracis<\/jats:italic>\n                    Ames strain spores in rabbits. A single dose of Wyeth\/IL-15\/PA protected 33% of the vaccinated A\/J mice against a lethal spore challenge 72 h later whereas a single dose of licensed anthrax vaccine protected only 10%. Our dual vaccine Wyeth\/IL-15\/PA remedies the inadequacies associated with the licensed vaccines, and the inherent ability of Wyeth vaccinia virus to be lyophilized without loss of potency makes it cold-chain independent, thus simplifying the logistics of storage, stockpiling, and field delivery in the event of a bioterror attack involving smallpox or anthrax.\n                  <\/jats:p>","DOI":"10.1073\/pnas.1013083107","type":"journal-article","created":{"date-parts":[[2010,10,4]],"date-time":"2010-10-04T22:41:48Z","timestamp":1286232108000},"page":"18091-18096","update-policy":"https:\/\/doi.org\/10.1073\/pnas.cm10313","source":"Crossref","is-referenced-by-count":22,"title":["Development of a highly efficacious vaccinia-based dual vaccine against smallpox and anthrax, two important bioterror entities"],"prefix":"10.1073","volume":"107","author":[{"given":"Tod J.","family":"Merkel","sequence":"first","affiliation":[{"name":"Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, MD 20892;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pin-Yu","family":"Perera","sequence":"additional","affiliation":[{"name":"Veterans Affairs Medical Center, Washington, DC 20422;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa K.","family":"Kelly","sequence":"additional","affiliation":[{"name":"Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, MD 20892;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anita","family":"Verma","sequence":"additional","affiliation":[{"name":"Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, MD 20892;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zara N.","family":"Llewellyn","sequence":"additional","affiliation":[{"name":"Southern Research Institute, Birmingham, AL 35255;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas A.","family":"Waldmann","sequence":"additional","affiliation":[{"name":"Metabolism Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph D.","family":"Mosca","sequence":"additional","affiliation":[{"name":"JDM Technologies, Ellicott City, MD 21042"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liyanage P.","family":"Perera","sequence":"additional","affiliation":[{"name":"Metabolism Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892; and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"341","published-online":{"date-parts":[[2010,10,4]]},"reference":[{"key":"e_1_3_3_1_2","volume-title":"Health Aspects of Chemical and Biological Weapons: A Report of a WHO Group of Consultants","author":"World Health Organization","year":"1970","unstructured":"; World Health Organization Health Aspects of Chemical and Biological Weapons: A Report of a WHO Group of Consultants (World Health Organization, Geneva, Switzerland, 1970)."},{"key":"e_1_3_3_2_2","doi-asserted-by":"publisher","DOI":"10.1086\/313812"},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","DOI":"10.1086\/518151"},{"key":"e_1_3_3_4_2","first-page":"93","article-title":"Recent progress in biodefence countermeasure development","volume":"5","author":"Mair M","year":"2007","unstructured":"M Mair, Recent progress in biodefence countermeasure development. Biosecur Bioterror 5, 93\u201396 (2007).","journal-title":"Biosecur Bioterror"},{"key":"e_1_3_3_5_2","volume-title":"Smallpox and Its Eradication History of International Public Health","author":"Fenner F","year":"1998","unstructured":"F Fenner, DA Henderson, I Arita, Z Jecek, ID Ladnyi Smallpox and Its Eradication History of International Public Health (World Health Organization, Geneva, Switzerland, 1998)."},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0923-2516(89)80126-8"},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.1517\/13543784.17.4.555"},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.2741\/3544"},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.1017\/S0022172400044272"},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2009.08.102"},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00538-07"},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2010.08.008"},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.71.3.1491-1496.2003"},{"key":"e_1_3_3_14_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.74.2.1009-1015.2006"},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.1128\/CVI.00081-08"},{"key":"e_1_3_3_16_2","first-page":"713","article-title":"Protective antigen and toxin neutralization antibody patterns in anthrax vaccinees undergoing serial plasmapheresis","volume":"12","author":"Pittman PR","year":"2005","unstructured":"PR Pittman, et al., Protective antigen and toxin neutralization antibody patterns in anthrax vaccinees undergoing serial plasmapheresis. Clin Diagn Lab Immunol 12, 713\u2013721 (2005).","journal-title":"Clin Diagn Lab Immunol"},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2003.07.004"},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(01)00234-1"},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2009.10.111"},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.1099\/00221287-147-6-1677"},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/0168-1656(95)00092-5"},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.micpath.2005.02.001"},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","DOI":"10.1128\/AEM.00369-08"},{"key":"e_1_3_3_24_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.01875-06"},{"key":"e_1_3_3_25_2","first-page":"132","volume-title":"World at Risk: The Report on the Commission on the Prevention of WMD Proliferation and Terrorism","author":"Graham B","year":"2008","unstructured":"B Graham, et al. World at Risk: The Report on the Commission on the Prevention of WMD Proliferation and Terrorism (Vintage Books, New York), pp. 132 (2008)."},{"key":"e_1_3_3_26_2","volume-title":"The Anthrax Vaccine: Is It Safe? Does It Work?","author":"IOM Committee to Assess the Safety and Efficacy of the Anthrax Vaccine","year":"2002","unstructured":"; IOM Committee to Assess the Safety and Efficacy of the Anthrax Vaccine The Anthrax Vaccine: Is It Safe? Does It Work? (National Academies Press, Washington, DC, 2002)."},{"key":"e_1_3_3_27_2","first-page":"235","volume-title":"Recombinant Poxviruses","author":"Buller RML","year":"1992","unstructured":"RML Buller, GJ Palumbo, Safety and attenuation of vaccinia viruses. Recombinant Poxviruses, eds MM Binns, GL Smith (CRC Press, Boca Raton, FL), pp. 235\u2013267 (1992)."},{"key":"e_1_3_3_28_2","doi-asserted-by":"publisher","DOI":"10.1038\/nri1901"},{"key":"e_1_3_3_29_2","doi-asserted-by":"publisher","DOI":"10.1038\/nri2580"},{"key":"e_1_3_3_30_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.1076071"},{"key":"e_1_3_3_31_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0630592100"},{"key":"e_1_3_3_32_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0406649101"},{"key":"e_1_3_3_33_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.59.6.1961-1965.1991"},{"key":"e_1_3_3_34_2","article-title":"Generation of recombinant vaccinia viruses","author":"Earl PL","year":"2001","unstructured":"PL Earl, B Moss, LS Wyatt, MW Carroll, Generation of recombinant vaccinia viruses. Curr Protoc Protein Sci, 5.13.1\u20135.13.19. (2001).","journal-title":"Curr Protoc Protein Sci"},{"key":"e_1_3_3_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/0378-1119(88)90439-8"}],"container-title":["Proceedings of the National Academy of Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pnas.org\/doi\/pdf\/10.1073\/pnas.1013083107","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,12]],"date-time":"2022-04-12T19:24:03Z","timestamp":1649791443000},"score":1,"resource":{"primary":{"URL":"https:\/\/pnas.org\/doi\/full\/10.1073\/pnas.1013083107"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,10,4]]},"references-count":35,"journal-issue":{"issue":"42","published-print":{"date-parts":[[2010,10,19]]}},"alternative-id":["10.1073\/pnas.1013083107"],"URL":"https:\/\/doi.org\/10.1073\/pnas.1013083107","relation":{},"ISSN":["0027-8424","1091-6490"],"issn-type":[{"value":"0027-8424","type":"print"},{"value":"1091-6490","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,10,4]]},"assertion":[{"value":"2010-10-04","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}